Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
about
Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication.Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin.Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retrovirusesAlteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC.Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.The yeast Ty3 retrotransposon contains a 5'-3' bipartite primer-binding site and encodes nucleocapsid protein NCp9 functionally homologous to HIV-1 NCp7Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response.Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo.Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.Role of HIV-1 RNA and protein determinants for the selective packaging of spliced and unspliced viral RNA and host U6 and 7SL RNA in virus particlesIdentification and characterization of a new type of inhibitor against the human immunodeficiency virus type-1 nucleocapsid protein.Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles.Human Discs Large is a new negative regulator of human immunodeficiency virus-1 infectivity.Nucleocapsid protein function in early infection processes.Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1)Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions.Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication.Mutations in the primer grip of human immunodeficiency virus type 1 reverse transcriptase impair proviral DNA synthesis and virion maturation.The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA.Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo.Role of RNA in facilitating Gag/Gag-Pol interaction.Functional surfaces of the human immunodeficiency virus type 1 capsid protein.Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.DNA condensation by the nucleocapsid protein of HIV-1: a mechanism ensuring DNA protection.The conserved N-terminal basic residues and zinc-finger motifs of HIV-1 nucleocapsid restrict the viral cDNA synthesis during virus formation and maturation.
P2860
Q28343701-82247C98-2734-425B-954D-751CF98767C3Q33643700-F8B913B9-9B7C-4521-953A-2A75781D21EEQ33782781-072A499C-F1BD-416C-A33F-77A7607CAFB7Q33800960-9F20FAC7-28AE-4989-91CF-F1259D5D7408Q33803814-66F158A2-603C-4436-8289-973228204F26Q33809367-152EE0DE-1757-4A62-B10F-17139B06CE77Q33834585-F55771D3-C7E5-4862-8124-995DF45B4C4CQ33845445-D54F00FB-BF0C-47A4-BD9A-809FB131EEC5Q33889345-04FB08FB-1AF3-4154-8344-6FB065A09FD8Q34012585-B5A024B7-A3E8-4EC8-89DC-4B0B4DBF3F01Q34343761-8C4DCF4D-7B8A-4F71-A011-EABCAE4567D8Q34461837-8D19F28B-32BD-40DC-AE2B-F3AE86780835Q34464770-3FC9B8EC-E415-45DB-A9B0-755A278AA2BFQ35468374-586B4D30-E2F7-48A5-8DC9-98B23AB8B79AQ36256762-38629E4A-C7CF-4EA1-A561-AFEE14F15AE0Q36329001-9E056057-0221-439E-BBA3-83BD83DC59D2Q37035170-1BFE51EE-B2BD-4269-AB99-8FE157000580Q37086413-076E9442-AFEA-4ECF-8459-FEAFD96B1D2FQ37530471-01F8F0C3-ABD5-47C9-83FA-BFEAEA29B200Q39549465-DDEE20C5-DA70-4E20-A239-4AFCCBF6BF48Q39578721-2ED29A55-3ECF-40A0-939D-3AA061F95009Q39580647-587F77C6-4644-4604-905D-26C2F0524F8FQ39596428-895942A8-9418-49E5-84A6-CB698401F5C0Q39610116-C60D8033-D1A7-48AE-B051-276F71089ED1Q39683238-13B075F0-C5B5-4671-A5FE-3808E9B7BFE3Q39748566-167F3260-C369-4926-8BDC-2B050647F829Q39795056-6E1F022F-C1DC-4CFA-8724-CA68CD5AAA64Q39922639-F6AA9137-7F86-4083-95CD-DD43D2DCCF1EQ39959233-C517F512-9645-4411-BB0C-6E0A481B2813
P2860
Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Mutations in the N-terminal do ...... re and proviral DNA synthesis.
@en
Mutations in the N-terminal do ...... re and proviral DNA synthesis.
@nl
type
label
Mutations in the N-terminal do ...... re and proviral DNA synthesis.
@en
Mutations in the N-terminal do ...... re and proviral DNA synthesis.
@nl
prefLabel
Mutations in the N-terminal do ...... re and proviral DNA synthesis.
@en
Mutations in the N-terminal do ...... re and proviral DNA synthesis.
@nl
P2093
P2860
P1433
P1476
Mutations in the N-terminal do ...... re and proviral DNA synthesis.
@en
P2093
P2860
P304
P407
P577
1997-09-01T00:00:00Z